Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
There is currently no universally accepted name for inflammatory disease of the eye and orbit associated with thyroid autoimmune disease. Variability in terminology impedes the evaluation of scientific literature and clinical collaboration and can affect patients’ understanding of a disease process....
Main Authors: | Lilly H. Wagner, Elizabeth A. Bradley, Andrea A. Tooley, Yanhan Ren, Kharisa N. Rachmasari, Marius N. Stan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1083886/full |
Similar Items
-
Graves’ ophthalmopathy – thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019-08-01) -
Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
by: Edelyn Christina, et al.
Published: (2023-06-01) -
Influence of biological sex, age and smoking on Graves’ orbitopathy – a ten-year tertiary referral center analysis
by: Michael Oeverhaus, et al.
Published: (2023-04-01) -
Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
by: P. Perros, et al.
Published: (2017-04-01) -
Editorial: News in Graves’ orbitopathy: patients management and treatments
by: Giulia Lanzolla, et al.
Published: (2023-08-01)